Altimmune

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Altimmune and other ETFs, options, and stocks.

About ALT

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH.

CEO

Vipin K. Garg

CEOVipin K. Garg

Employees

Employees59

Headquarters

Gaithersburg, Maryland

HeadquartersGaithersburg, Maryland

Founded

1997

Founded1997

Employees

Employees59

ALT Key Statistics

Market cap

388.15M

Market cap388.15M

Price-Earnings ratio

-3.78

Price-Earnings ratio-3.78

Dividend yield

—

Dividend yield—

Average volume

1.68M

Average volume1.68M

High today

$5.23

High today$5.23

Low today

$4.93

Low today$4.93

Open price

$5.08

Open price$5.08

Volume

1.77M

Volume1.77M

52 Week high

$11.16

52 Week high$11.16

52 Week low

$3.55

52 Week low$3.55

ALT News

Simply Wall St 3d

After losing 30% in the past year, Altimmune, Inc. institutional owners must be relieved by the recent gain

Key Insights Institutions' substantial holdings in Altimmune implies that they have significant influence over the company's share price A total of 25 investo...

Analyst ratings

90%

of 10 ratings

Buy

90%

Hold

10%

Sell